Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
32 results
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy
D1.156 - Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients
D1.157 - Type II Cytokine-Mediated Regulation of Alarmin Receptors in B Cells: Implications for Eosinophilic Esophagitis
D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment
D2.33 - Correlation of chronic rhinosinusitis and lung function in allergy patients with chronic cough
D2.34 - Generalized allergic contact dermatitis: a case report
D2.35 - Prevalence of the sensitivity to aeroallergens among patients with asthma and allergic rhinitis (AR), based on skin prick test (SPT) and its seasonal variation
D2.36 - Clinical Outcomes Of Dental Procedures In Patients With Hereditary Angioedema
D2.37 - Prevalence of food cross-sensitization due to PR-10 proteins among patients of different age groups
D2.38 - Clinical Evaluation of Alternaria alternata Extract Used for Skin Prick Test in Diagnosis of Alternaria alternata Allergy
D2.39 - Diagnostic performance of IgE sensitization with Blomia tropicalis for prediction of positive nasal challenge test
D2.42 - Clinical relevance of secondary sensitizations to indoor allergens in patients with persistent allergic rhinitis in a region with high prevalence of dust mite allergy
D2.43 - Implementation of the New Italian Health Care Price List: Impact on Allergy Diagnostics
D2.44 - Kiwi Allergy in Singaporean Children
D2.45 - Specific IgE for inhalant allergens: A cutoff of 0.35 kUA/L is too low
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download